Big pharma and biotechs are investing more than $1 Billion in cancer research Unlisted Video

Scientists are currently developing cutting edge medical advances that could change the way everything from cancer to Alzheimer's disease and autoimmune diseases are treated. Cancer has become the primary focus of the new technology, called targeted protein degradation or PROTAC.